Both in Pharmaceuticals
Pacira BioSciences vs uniQure
Over the past year PCRX returned +60.1% and QURE returned −64.4%; their daily moves had a correlation of -0.04.
PCRX +60.1% QURE −64.4%Growth of $1, one year, split-adjusted
| Metric | PCRX | QURE |
|---|---|---|
| Price | $36.40 | $20.97 |
| Market cap | $1.45B | $1.45B |
| Today | +0.25% | −1.46% |
| 1 month | +51.2% | −51.3% |
| 6 months | +55.4% | +21.6% |
| Year to date | +40.6% | −12.4% |
| 1 year | +63.5% | −66.2% |
| Revenue growth (YoY) | +6.2% | +11.0% |
| Gross margin | 77.0% | 94.0% |
| Net margin | 2.4% | −1387.8% |
| P/E (TTM) | 99.2× | — |
| Price / sales | 1.9× | 77.9× |
| Net cash | -$112.1M | $760.2M |
| Dividend yield | — | — |
| Volatility (60d) | 82.8% | 106.1% |
| Short % of float | 21.2% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).